Such investigations are highly warranted to understand the role of LRG-1 and its potential molecular and cellular interaction partners in different stages of tumorigenesis, i.e., ranging from precancerous lesions to overt BC metastases in clinically relevant organs, including bone, lungs, or the brain. Here, LRG1 is linked to breast cancer.